These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5951782)

  • 1. Flu hybrids: a cause of vaccine obsolescence?
    Kilbourne ED; Schulman J; Jahiel R; Lief F; Laver WG
    JAMA; 1966 Feb; 195(8):Suppl:50. PubMed ID: 5951782
    [No Abstract]   [Full Text] [Related]  

  • 2. Hybridization studies with the RNA of the WS strain of influenza virus and its neurotropic variant NWS.
    Hobson D; Scholtissek C
    J Gen Virol; 1970 Nov; 9(2):151-3. PubMed ID: 5483405
    [No Abstract]   [Full Text] [Related]  

  • 3. [On transfering of genetic traits with the use of RNA isolated from influenza viruses].
    Sokolov MI; Podcherniaeva RIa; Men'shikh LK
    Vopr Virusol; 1965; 10(2):139-42. PubMed ID: 5892680
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
    Mailybayeva A; Yespembetov B; Ryskeldinova S; Zinina N; Sansyzbay A; Renukaradhya GJ; Petrovsky N; Tabynov K
    PLoS One; 2017; 12(10):e0186484. PubMed ID: 29023541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic composition of a high-yielding influenza A virus recombinant: a vaccine strain against "Swine" influenza.
    Palese P; Ritchey MB; Schulman JL; Kilbourne ED
    Science; 1976 Oct; 194(4262):334-5. PubMed ID: 968486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HYBRIDIZATION OF INFLUENZA VIRUSES. I. METHODS AND CONDITIONS FOR OBTAINING INFLUENZA VIRUS HYBRIDS].
    SOKOLOV MI; PODCHERNIAEVA RIa; DAVYDOVA AA
    Vopr Virusol; 1963; 67():547-53. PubMed ID: 14082495
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of gamma-irradiation conditions on the immunogenicity of whole-inactivated Influenza A virus vaccine.
    David SC; Lau J; Singleton EV; Babb R; Davies J; Hirst TR; McColl SR; Paton JC; Alsharifi M
    Vaccine; 2017 Feb; 35(7):1071-1079. PubMed ID: 28109709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HYBRIDIZATION OF INFLUENZA VIRUSES. 2. CHANGE IN THE PROPERTIES OF HYBRIDS OF INFLUENZA VIRUSES].
    PODCHERNIAEVA RI; SOKOLOV MI
    Vopr Virusol; 1963; 126():697-701. PubMed ID: 14139254
    [No Abstract]   [Full Text] [Related]  

  • 9. Flu in 15: a novel 15-minute education program to promote acceptance of the influenza vaccine among health care workers.
    Butteri MJ; Radu C; Huq F; Wiglesworth A; Durso SC; Bellantoni M
    J Am Med Dir Assoc; 2010 Sep; 11(7):523-7. PubMed ID: 20816342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Functional Food Mixture "Protector" Reinforces the Protective Immune Parameters against Viral Flu Infection in Mice.
    Mansoor KA; Qadan F; Schmidt M; Qinna NA; Badr M; Matalka KZ
    Nutrients; 2018 Jun; 10(6):. PubMed ID: 29890620
    [No Abstract]   [Full Text] [Related]  

  • 11. First evaluation of an influenza viral vector based Brucella abortus vaccine in sheep and goats: Assessment of safety, immunogenicity and protective efficacy against Brucella melitensis infection.
    Tabynov K; Yespembetov B; Matikhan N; Ryskeldinova S; Zinina N; Kydyrbayev Z; Assanzhanova N; Tabynov K; Renukaradhya GJ; Mukhitdinova G; Sansyzbay A
    Vet Microbiol; 2016 Dec; 197():15-20. PubMed ID: 27938677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Defective particles in a virus population].
    Kantorovich EN
    Vopr Virusol; 1973; 18(3):259-66. PubMed ID: 4358704
    [No Abstract]   [Full Text] [Related]  

  • 13. RNA oncogenic viruses: structure, replication, and oncogenicity.
    Vigier P
    Prog Med Virol; 1970; 12():240-83. PubMed ID: 4921482
    [No Abstract]   [Full Text] [Related]  

  • 14. Revisiting the 1976 "swine flu" vaccine clinical trials: cross-reactive hemagglutinin and neuraminidase antibodies and their role in protection against the 2009 H1N1 pandemic virus in mice.
    Xie H; Li X; Gao J; Lin Z; Jing X; Plant E; Zoueva O; Eichelberger MC; Ye Z
    Clin Infect Dis; 2011 Dec; 53(12):1179-87. PubMed ID: 21976461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous subcutaneous and conjunctival administration of the influenza viral vector based Brucella abortus vaccine to pregnant heifers provides better protection against B. abortus 544 infection than the commercial B. abortus S19 vaccine.
    Tabynov K; Orynbayev M; Renukaradhya GJ; Sansyzbay A
    Vaccine; 2016 Sep; 34(42):5049-5052. PubMed ID: 27595898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A one-size-fits-all flu vaccine?
    Kaiser J
    Science; 2006 Apr; 312(5772):380-2. PubMed ID: 16627732
    [No Abstract]   [Full Text] [Related]  

  • 17. Infectious diseases. Experts dismiss pig flu scare as nonsense.
    Enserink M
    Science; 2005 Mar; 307(5714):1392. PubMed ID: 15746398
    [No Abstract]   [Full Text] [Related]  

  • 18. Viral double-stranded RNA, cytokines, and the flu.
    Majde JA
    J Interferon Cytokine Res; 2000 Mar; 20(3):259-72. PubMed ID: 10762073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza.
    Huber VC; McKeon RM; Brackin MN; Miller LA; Keating R; Brown SA; Makarova N; Perez DR; Macdonald GH; McCullers JA
    Clin Vaccine Immunol; 2006 Sep; 13(9):981-90. PubMed ID: 16960108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of PapMV nanoparticles on the kinetics of the antibody response to flu vaccine.
    Rioux G; Carignan D; Russell A; Bolduc M; Gagné MÈ; Savard P; Leclerc D
    J Nanobiotechnology; 2016 Jun; 14(1):43. PubMed ID: 27282291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.